Get all your news in one place.
100's of premium titles.
One app.
Start reading
WEKU
WEKU
Health
Joe Palca

Whatever happened to the new no-patent COVID vaccine touted as a global game changer?

The Corbevax vaccine was invented at the Center for Vaccine Development at Texas Children's Hospital and intended for countries that couldn't get access to more expensive COVID vaccines. India has inoculated millions of teens with Corbevax (above, a vaccination drive for children ages 12-14 at a school in Bangalore) and on August 10 authorized the vaccine as a booster for adults. (Manjunath Kiran/AFP via Getty Images)

About This Series

Over the next week, we'll be looking back at some of our favorite Goats and Soda stories to see "whatever happened to ..."

Back in January, we told you about a different kind of COVID vaccine that had just been approved for use in India. The vaccine, called Corbevax, had some very attractive properties: It's low-cost, easy to make using well-established biotech processes — and patent-free.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.